Pulmonologist – Dr Steven Dubinett

Steven Dubinett, MD is a pulmonologist located in Los Angeles. He obtained his medical degree from Rutgers New Jersey Medical School. Currently he practices at VA Greater Los Angeles Plm Crt Cr and offers services through various insurance plans.

He is well-versed in translational research, academic administration and mentorship; having participated as part of the NCI Translational Research Working Group as well as numerous NIH study sections and Special Emphasis Panels.

Early Life and Education

Steven Dubinett earned his medical degree from the University of New Jersey Medical School before going on to complete a residency at UCLA Health System followed by a fellowship in pulmonary medicine and tumor immunology at Massachusetts General Hospital and Harvard Medical School.

Dr. Ho studies immunity and inflammation as they pertain to lung cancer development. For over thirty years he has received steady funding from federal sources to bring lab discoveries into clinical investigation and patient care.

Associat Vice Chancellor for Research and Director of UCLA Jonsson Cancer Center Lung Cancer Research Program. Additionally he serves as Chief of Pulmonary and Critical Care Medicine as well as being jointly appointed professor in departments such as Medicine, Pathology & Laboratory Medicine,Molecular & Medical Pharmacology at UCLA. With more than 45 graduate students, post-doctoral fellows,junior faculty all of whom continue in academic or industry research careers under his tutelage he possesses extensive expertise in translational investigation, academic administration,mentorship as well as mentorship; training over 45 graduate students/post-doctoral fellows/junior Faculty most of whom continue in academic or industry research careers he has provided him training that has produced many academic or industry researchers.

Professional Career

Steven Dubinett has over 42 years of research experience in pulmonary medicine. After receiving his MD/Dentistry from University of Medicine and Dentistry of New Jersey / Newark in 1980, he currently practices at VA Greater Los Angls Plm Crt Ctr.

Nationally recognized for his translational research into lung cancer immunobiology, his lab was one of the first to identify inflammation-dependent genes and proteins involved in angiogenesis, apoptosis resistance, invasion, and immune suppression – pioneering groundbreaking discoveries regarding human non-small cell lung cancer (NSCLC).

He is supported in his research efforts by various organizations. Furthermore, he has trained over 45 graduate students, postdoctoral fellows and junior faculty members – most of which remain engaged in academic or industry research today. Furthermore, he serves as both associate vice chancellor of research at UCLA and director of UC Clinical & Translational Science Institute.

Achievement and Honors

Steven Dubinett has become widely recognized for his pioneering research in Immunology, Lung cancer and cancer. His studies include Angiogenesis and Carcinogenesis for cancer; for Lung cancer specifically Adenocarcinoma. As for his Immune system research this includes elements like Cytokine production and Myeloid-derived Suppressor Cell.

Dr. Barlow has received many honors and awards over his career, most recently receiving the Assembly on Thoracic Oncology Lifetime Achievement Award from the American Thoracic Society in 2023.

He is an exceptionally creative scientist who believes in closely inspecting scientific data and challenging conventional thoughts, pushing his mind in new directions. This approach has yielded remarkable discoveries between inflammation and lung cancer.

Personal Life

Dr. Dubinett specializes in Pulmonology and has over 42 years of experience as a practicing doctor. He attended the UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY/ NEWARK to receive his education.

He currently practices at VA Greater Los Angeles Plm Crt Cr, as well as being affiliated with UCLA Jonsson Cancer Center and NCI Translational Research Working Group.

He has discovered unexpected connections between lung disease and inflammation, receiving continuous federal peer-reviewed funding to conduct translational immunobiology of lung cancer research. Over this time he has mentored over 50 graduate students, postdoctoral fellows and junior faculty – most of which have since gone onto academic or industry research careers. His primary research interest focuses on understanding how the tumor microenvironment influences non-small cell lung cancer development in humans.